Pharmafile Logo
Pharmafocus logo
Advanced Search

US

Showing 15 posts of 324 posts found.

legal

Antitrust investigation launched into Mylan and the EpiPen scandal

September 7, 2016
Research and Development, Sales and Marketing Mylan, US, antitrust, epipen, investigation, lawmakers, scandal

The New York attorney general has commenced an investigation into Mylan Pharmaceuticals, after an initial review indicated that the company …

News
hils

Clinton announces plan to tackle “unjustified price hikes”

September 5, 2016
Sales and Marketing Drug pricing, Shkreli, US, clinton, generic drugs, president, price hikes

US Presidential candidate Hillary Clinton has outlined a wide-ranging set of proposals to tackle what she calls the “unjustified price …

News
mylan_plus_hero_720x510

Mylan latest target of US anger on drug pricing with EpiPen price increase

August 24, 2016
Research and Development, Sales and Marketing Mylan, US, congress, controversy, epipen, price gouging, price increase

The US congress is again subjecting the pharmaceutical industry to heavy scrutiny over drug pricing policies with Mylan its latest …

News
opdivo_1

Opdivo to go before EU, US regulators in head and neck cancer

July 19, 2016
Manufacturing and Production, Research and Development EMA, EU, FDA, US, head and neck cancer, opdivo

Bristol-Myers Squibb has announced that its lead oncology drug, Opdivo (nivolumab), is set to go before regulators in the US …

News

US doctors received $6.5 billion from drug, device firms in 2015

July 1, 2016
Medical Communications, Research and Development, Sales and Marketing US, affordable care act, pharma, regulation

Doctors and hospitals received nearly $6.5 billion in research and speaking fees as well as other goods or services from …

News
allergan

FDA approves Allergan hypertension fixed-dose combo, Byvalson

June 7, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, FDA, US, angiotensin ii, approval, beta blocker, byvalson, hypertension, nebivolol, valsartan

Allergan has announced that the US Food and Drug Administration (FDA) has approved its fixed-dose combination, Byvalson (nebivolol and valsartan), …

News
lab

Eisai partners with Novartis in renal cell carcinoma collaboration

June 3, 2016
Medical Communications, Sales and Marketing Afinitor, Eisai, Lenvima, Novartis, US, everolimus, lenvatinib mesylate

Eisai (TYO: 4523) has announced that it has entered into a partnership with Novartis Pharmaceuticals to collaborate on commercial and …

News
doc_writing

US pass new laws to combat opioid epidemic

May 13, 2016
Medical Communications, Sales and Marketing US, epidemic, fight back, new laws, opioids, reverse

The US has passed new laws that will seek to combat the current epidemic of opioids across the country. The …

News

US biotech company to try resurrect the clinically dead

May 4, 2016
Research and Development US, bioquark, biotech, brain, central nervous system, clinically dead, dead, patients, ressurect

A US biotech firm has announced plans for a Phase I trial that will see them attempt to bring brain-dead …

News
pfizer_finland_hq

Pfizer to pay $784.6 million fine due to Wyeth Medicaid fraud

April 28, 2016
Medical Communications, Sales and Marketing False Claims Act, Medicaid, Pfizer, US, Wyeth, department, fraud, insurer, justice

Pfizer has agreed to pay $784.6 million in a settlement with the US Department of Justice, relating to false and …

News
valeant

Valeant’s outgoing CEO subpoenaed by US congressional committee

March 29, 2016
Medical Communications, Research and Development Drug pricing, Michael Pearson, US, Valeant, committee, pearson, pharma, price hikes, senate aging committee, subpoena, subpoenaed

The US Senate Aging Committee has announced the issuing of a subpoena to the outgoing CEO of Valeant Pharmaceuticals, Michael …

News
disease

FDA approves new anthrax treatment

March 22, 2016
Manufacturing and Production, Research and Development Antibacterial, FDA, US, anthim, anthrax, defense, inhalational

The US Food and Drug Administration (FDA) has approved Anthim (obiltoxaximab) to treat inhalational anthrax in combination with appropriate antibacterial …

News
magic_bullets_pills

Almost half of US physicians will prescribe more biosimilars, according to survey

March 4, 2016
Medical Communications Obama, US, biosimilar, patent, prescribing

New data published by InCrowd has suggested that US physicians are very amenable to the prescription of biosimilars, with some …

News
Shkreli hearing

Big pharma answers tough questions at US drug pricing hearing

February 5, 2016
Medical Communications Drug pricing, FDA, Martin Shkreli, Senate, Turing Pharmaceuticals, US, Valeant, congress

Pharmaceutical industry executives came under intense scrutiny at a Congressional hearing in the US as the debate over the spiralling …

News
Obama_SOTU

Big pharma joins President Obama’s cancer ‘moonshot’

January 13, 2016
Research and Development Amgen, Cancer, Celgene, National Immunotherapy Coalition, President Barack Obama, US, moonshot

Celgene and Amgen are among the large biopharma companies that have agreed to join the National Immunotherapy Coalition (NIC), a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025